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Background: The high prevalence of cardiovascular risk factors among the renal transplant population accounts for
increased mortality. The aim of this study is to determine the incidence of cardiovascular events and factors associated
with cardiovascular events in these patients.
Methods: An observational ambispective follow-up study of renal transplant recipients (n = 2029) in the health district
of A Coruña (Spain) during the period 1981–2011 was completed. Competing risk survival analysis methods were applied
to estimate the cumulative incidence of developing cardiovascular events over time and to identify which characteristics
were associated with the risk of these events.
Post-transplant cardiovascular events are defined as the presence of myocardial infarction, invasive coronary
artery therapy, cerebral vascular events, new-onset angina, congestive heart failure, rhythm disturbances, peripheral vascular
disease and cardiovascular disease and death. The cause of death was identified through the medical history and death
certificate using ICD9 (390–459, except: 427.5, 435, 446, 459.0).
Results: The mean age of patients at the time of transplantation was 47.0 ± 14.2 years; 62% were male. 16.5%
had suffered some cardiovascular disease prior to transplantation and 9.7% had suffered a cardiovascular event. The mean
follow-up period for the patients with cardiovascular event was 3.5 ± 4.3 years. Applying competing risk methodology, it
was observed that the accumulated incidence of the event was 5.0% one year after transplantation, 8.1% after five years,
and 11.9% after ten years. After applying multivariate models, the variables with an independent effect for predicting
cardiovascular events are: male sex, age of recipient, previous cardiovascular disorders, pre-transplant smoking
and post-transplant diabetes.
Conclusions: This study makes it possible to determine in kidney transplant patients, taking into account competitive
events, the incidence of post-transplant cardiovascular events and the risk factors of these events. Modifiable risk factors
are identified, owing to which, changes in said factors would have a bearing of the incidence of events.
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Cardiovascular disease is one of the most common com-
plications after renal transplantation [1]. Although some
authors have documented a significant reduction in
cardiovascular death after kidney transplantation [2],
today cardiovascular disease is still the major known
cause of death in kidney transplant patients [3].
Long-term graft failure is secondary to chronic
allograft nephropathy, recurrent disease, and death with
a functioning graft. Recurrent disease is becoming an
important cause of late graft failure and cardiovascular
illnesses and neoplasms are the two main causes of
death with normal function of the graft in the long-term
follow-up of kidney transplant patients [4].
Conventional cardiovascular risk factors such as
hyperlipidaemia, hypertension and diabetes are common
in transplant recipients, partly because of the effects of
immunosuppressive drugs, and are associated with
adverse outcomes [5, 6]. Determining the incidence of
cardiovascular events after a kidney transplant and the
associated risk factors is important to inform physicians
of the need of cardiovascular disease screening and
prevention as part of the transplant evaluation [7, 8]. On
the other hand, an accurate estimation of a patient’s risk
of cardiovascular disease could allow identifying people
at risk of a cardiovascular event and intervene before
they develop the disease.
The study was conducted with the aim determining
the incidence of cardiovascular events and the variables
associated with the same, employing competing risk
methodology to estimate the events of interest.
Methods
Study type
Ambispective observational follow-up study within a co-
hort of renal-transplant recipients. The protocol of this
study has been already published [9].
Research setting
The study included all the kidney transplants performed
at the Nephrology Department of Complejo Hospitalario
Universitario de A Coruña (Spain) during 1981–2011.
This hospital is of reference at a regional level for kidney
transplantation and at a national level for combined
kidney-pancreas transplantation. It is a 1,382-bed public
tertiary care hospital attending a population of nearly
560,000 habitants.
Study population
An observational prospective follow-up study with a
retrospective component during the period 1981–2011
was completed. During said period 2,313 kidney trans-
plants were performed, corresponding to 2,029 patients.Patients who had received transplants were identified
through the hospital’s transplant registry.
Measurements
For each patient, information included donor and recipient
characteristics, patient and graft survival after transplant-
ation. Information about cardiovascular risk factors at the
time of transplantation was also collected and post-
transplant cardiovascular events were registered. The
follow-up period for each patient starts on the day of trans-
plantation and continues until death or last reported
contact.
Post-transplant cardiovascular events are defined as the
presence of myocardial infarction, invasive coronary artery
therapy (coronary balloon angioplasty, stents and bypass
surgery), cerebral vascular events (stroke and transient
ischemic attacks), new-onset angina, congestive heart fail-
ure, rhythm disturbances (ventricular tachycardia, atrial
fibrillation and the need for a pacemaker), peripheral
vascular disease and cardiovascular disease, death. The
cause of death was identified through the medical history
and death certificate using ICD9 (390–459, except: 427.5,
435, 446, 459.0).
Sample size justification
The sample size (n = 2,029) makes it possible to detect
as significant HR ≥ 1.305 with a prevalence of exposure
to a risk factor of 50% and a censored data percentage of
78% (Security: 95%; Statistical power: 80%).
Statistical analysis
A descriptive analysis of the variables recorded was per-
formed. Competing risk survival analysis methods were
applied to estimate the cumulative incidence of develop-
ing events over time from kidney transplantation. These
methods allow for the fact that a patient may experience
an event which is different from that of interest. These
events are known as competing risk events, and may
preclude the onset of the event of interest, or may
modify the probability of the onset of that event. In par-
ticular, a transplanted patient may die or lose the graft
without suffering a cardiovascular event. In a Kaplan-
Meier estimation approach, these individuals would be
treated as censored and would be eliminated from the
risk set, leading to misleading results. Using competing
risks, the probability of any event happening is parti-
tioned into the probabilities for each type of event.
To determine cardiovascular event-free survival, the
primary outcome was the estimation of the probability
of cardiovascular disease.
The accumulated occurrence of cardiovascular disease
during the follow-up period was estimated using the method
proposed by Kalbfleisch and Prentice [10]. The accumulated
occurrence of cardiovascular events according to different
Table 1 Baseline characteristics and cardiovascular risk factors
of the kidney transplant recipients
Baseline characteristics Mean SD Median
Age of recipient (years) 46.97 14.2 49.00
Age of donor (years) 42.07 18.7 44.00
Time in renal replacement
therapy (months)
31.1 35.0 20.00
n % 95% CI
Gender of recipient
Men 1266/2029 62.4 60.3–64.5
Women 763/2029 37.6 35.5–39.7
Gender of donor
Men 1329/1982 67.1 65.0–69.1
Women 653/1982 32.9 30.9–35.0
Live donor 83/1939 4.3 3.4–5.2
Pre-transplant substitutive renal therapy
Haemodialysis 1462/1951 74.9 73.0–76.9
Peritoneal dialysis 489/1951 25.1 23.1–27.0
Prior transplant
First transplant 1745/2029 86.0 84.5–87.5
Re-transplant 284/2029 14.0 12.5–15.5
DR compatibilities
0 184/1942 9.5 8.1–10.8
1 1340/1942 69.0 66.9–71.1
2 418/1942 21.5 19.7–23.4
ABO Compatibilities
0 377/1955 19.3 17.5–21.1
1 791/1955 40.5 38.3–42.7
2 660/1955 33.8 31.6–35.9
3 101/1955 5.2 4.2–6.2
4 26/1955 1.3 0.8–1.9
Type of transplant
Kidney 1927/2008 95.5 94.6–96.4
Kidney + liver 19/2008 0.94 0.5–1.4
Kidney + pancreas 55/2008 2.73 2.0–3.5
Kidney + heart 12/2008 0.59 0.2–0.9
Kidney + heart + liver 1/2008 0.05 0.001–0.3
Kidney + lung 4/2008 0.20 0.05–0.5
Cardiovascular Risk Factors n % 95% CI
Previous cardiovascular disease 328/1983 16.5 14.9–18.2
Obesity (BMI≥ 30kg/m2) 191/1598 12.0 10.3–13.6




Pre-transplant diabetes mellitus 176/1999 8.8 7.5–10.1
Pre-transplant smoker 477/1007 47.4 44.2–50.5
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Gray [11]. Finally, in order to identify which characteristics
were associated with the risk of cardiovascular events, a
multivariate analysis was carried out using the model pro-
posed by Fine and Gray [12]. All of the tests were carried
out bilaterally, considering values of p < 0.05 as significant.
The analyses were carried out using the programmes R 3.2.3
and SPSS 19.0.
Results
The baseline characteristics of the kidney transplant
recipients are given in Table 1.
During the study period, a total of 2,313 transplants
were performed at the University Hospital Complex in
A Coruña, corresponding to n = 2,029 patients. The
characteristics of the transplants performed and the
prevalence of cardiovascular risk factors at the time of
transplantation are shown in Table 1.
The graft continued to function at the end of follow-
up in 53.3% of transplants, the graft was lost in 30.2% of
cases and 16.5% of patients did not survive. Among the
causes of death with a functioning graft, the most fre-
quent were infections (28.4%), cardiovascular disease
(24.2%) and post-transplant cancer (10.5%). A total of
9.7% of transplantation patients suffered a cardiovascular
event during follow-up.
If we analyse the incidence of cardiovascular events and
factors associated with the same, it can be observed that
the rate of incidence per 1,000 individuals-year of follow-
up for cardiovascular events is 22.9 (95% CI: 19.8–26.3),
with the mean time elapsed from transplantation to the
onset of the cardiovascular event being 3.5 ± 4.3 years. It
can be seen that the rate is higher in men than in women
(26.8 vs. 16.6 per 1,000 individuals/year; p = 0.003) and
increases in proportion to the recipient’s age. In patients
aged 45 or under, the incidence rate is 12.0 × 1000 individ-
uals/year. Between 46 and 55 years of age, the incidence
rate is 26.7 × 1000 individuals/year. In the 56–65 year old
age group, it is 3.0 × 1000 individuals/year, and for patients
over 65 years of age, it is 69.1 × 1000 individuals/year.
Applying competing risk methodology, it can be
observed that the accumulated incidence for cardiovas-
cular events one year after transplantation, after two
years, after five years and after ten years, is 5.0, 5.6, 8.1
and 11.9%, respectively (Fig. 1).
The bivariate analysis (Table 2) shows that patients ex-
periencing a cardiovascular event are generally older. At
the end of follow-up, 11.2% of the males had suffered a
cardiovascular event as opposed to 7.2% of women. The
highest percentage of events was in pre-transplantation
smokers and post transplantation smokers, in patients
with previous cardiovascular disease (cerebral vascular
events (stroke and transient ischemic attacks), ischemic
heart disease, congestive heart failure, peripheral vascular
Fig. 1 Accumulated incidents according to event (cardiovascular
event, loss of graft or death of the patient)
Table 2 Comparison of recipient kidney transplant according to pre
No Cardiovascular Event Card
Mean ± sd Mea
Receptor age 46.5 ± 14.4 51.5
Weight (Kg) 67.9 ± 22.5 69.8
BMI (kg/m2) 25.3 ± 8.3 25.9
Proteinuria (g/24h) 0.5 ± 0.9 0.6 ±
Hemoglobin (g/dL) 10.0 ± 2.9 9.0 ±
Hematocrit (%) 32.7 ± 8.9 31.8
Glomerular filtration rate estimated
(Cockroft-Gault)
44.5 ± 24.4 43.8
Glomerular filtration rate estimated (MDRD) 40.5 ± 25.5 39.9
Glomerular filtration rate estimated (CKD-EPI) 50.1 ± 31.5 44.8
Systolic blood pressure (mmHg) 141.6 ± 21.3 145
Diastolic blood pressure (mmHg) 81.9 ± 12.4 81.3
Cholesterol (mg/dL) 147.8 ± 40.4 152
Cholesterol HDL (mg/dL) 40.6 ± 17.8 36.9
Cholesterol LDL (mg/dL) 121.2 ± 35.6 111
Triglycerides (mg/dL) 140.7 ± 73.5 150
Glucose (mg/dL) 120.1 ± 59.7 124
Event in exposed subjects Eve
n (%) n (%
Gender (ref:woman) 142 (11.2) 55 (
Previous cardiovascular illness 65 (19.8) 131
Pre-transplantation smokers 65 (13.1) 33 (
Post-transplantation smokers 22 (15.0) 69 (
Pre-transplantation hypertension 165 (9.7) 30 (
Post-transplantation hypertension 193 (10.3) 4 (3
Diabetes 67 (14.0) 129
Left ventricular hypertrophy 109 (13.9) 75 (
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post-transplantation blood pressure, in those with left
ventricular hypertrophy and post-transplant diabetes.
Patients with cardiovascular events had higher levels of gly-
cemic control than patients without cardiovascular events.
After modelling the incidence of cardiovascular events
employing specific competing risk techniques, with the
patient’s death or graft loss being those events compet-
ing with the presence of the event of interest, adjusting
for different factors, it can be seen that those variables
with a bearing on the presence of cardiovascular events
subsequent to kidney transplantation are male gender,
age of the recipient, prior cardiovascular disease,
pre-transplant smoking and diabetes (Table 3).
Discussion
In this study, data were collected on 2,029 kidney trans-
plant patients, with a mean age of 47.0 ± 14.2 years, and
62.4% of which were men. A cardiovascular event was
suffered by 9.7% of these patients. The accumulated inci-
dence of a cardiovascular event in the presence ofsence or absence of cardiovascular event
iovascular Event Univariate Survival Models
n ± sd Sig, HR 95% CI (HR)
± 11.5 <0.001 1.038 1.026 1.049
± 13.5 0.015 1.004 1.001 1.007
± 3.9 0.050 1.009 1.000 1.019
1.0 0.086 1.112 0.985 1.256
2.7 0.685 0.958 0.777 1.180
± 7.1 0.417 1.006 0.992 1.020
± 22.9 0.182 0.995 0.988 1.002
± 24.5 0.120 0.995 0.989 1.001
± 28.2 0.062 0.995 0.990 1.001
.3 ± 22.3 0.230 1.004 0.998 1.010
± 11.6 0.195 0.992 0.981 1.004
.3 ± 42.6 0.717 1.001 0.997 1.004
± 15.4 0.580 0.993 0.969 1.017
.6 ± 41.9 0.349 0.992 0.976 1.009
.8 ± 77.0 0.266 1.001 0.999 1.003
.7 ± 49.7 0.190 1.001 0.999 1.002
nt in unexposed subjects Univariate Survival Models
) Sig. Exp(β) = HR 95% CI (HR)
7.2) 0.002 1.615 1.182 2.205
(7.9) <0.001 2.972 2.206 4.004
6.5) <0.001 2.819 1.842 4.316
8.2) <0.001 2.323 1.434 3.763
10.6) 0.472 1.154 0.781 1.707
.6) 0.037 2.872 1.067 7.731
(8.5) <0.001 1.820 1.360 2.430
7.0) <0.001 2.150 1.602 2.886
Table 3 Multivariate competing risk regression model of a
cardiovascular event after kidney trasplantation
β se (β) p HR 95% CI
Gender (ref: woman) 0.589 0.288 0.041 1.80 1.02 3.17
Receptor age 0.021 0.007 0.005 1.02 1.01 1.04
Previous cardiovascular
illness
0.655 0.221 0.003 1.92 1.25 2.97
Pre-transplant smoking 0.558 0.242 0.021 1.75 1.09 2.81
Post-transplant diabetes
mellitus
0.585 0.212 0.006 1.79 1.18 2.72
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years, 8.1% after five years and 11.9% after ten years. These
results are consistent with those published in multicentre
studies, including data from transplanted patients from
North America, Europe and countries on the Pacific coast,
in which the accumulated incidence of coronary events
and the accumulated incidence of myocardial infarct after
kidney transplant is estimated [13, 14].
Various epidemiological studies have identified the
factors associated with an increase in the probability of
falling ill or dying owing to cardiovascular disease after
kidney transplantation [15–17]. They also test whether
the risk factors identified for the general population also
increased the risks in kidney transplant patients and to
what extent. These studies would suggest that the
cardiovascular risk factors for the general population
(e.g. high blood pressure, hyperlipidaemia and smoking)
are predictive of events in the transplanted population.
Diabetes doubles the risk of events in men and triples
the risk in women with respect to that estimated for the
general population; moreover, it is shown that the
episodes of acute rejection during the first year after trans-
plantation are associated with a greater risk [15, 16]. In
the study by Weiner, D. E. [17] the factors associated sig-
nificantly with an increased risk of cardiovascular disease
in transplanted patients were old-age, prior cardiovascular
disease, diabetes, smoking, systolic and diastolic blood
pressure and low BMI and glomerular filtration rates
estimated with the CKD-EPI formula lower than
45ml/min/1.73m2. Other traditional risk factors in the
general population, such as gender, LDL Cholesterol
and triglycerides, were not significant.
For cerebrovascular disease (ischaemic cerebrovascular
accident, haemorrhagic cerebrovascular accidents and
transient ischaemic attacks) after kidney transplantation,
the risk factors were age, pre-and post-transplant smok-
ing, diabetes, high blood pressure, obesity and coronary
comorbidity [5].
The results of our study are consistent with those in
the literature. After performing survival models, we have
identified the following as predictors of cardiovascular
events: male gender, age of recipient, the presence ofprior cardiovascular disease, pre-transplant smoking and
post-transplant diabetes. The presence of these factors
along with the higher age of the recipient increases the
risk of cardiovascular events.
Here we should stress the importance of complications
related with immunosuppressant treatment, of which
diabetes mellitus is perhaps most important, owing to
the vascular problems it gives rise to [18–21]. We
believe that the prevention of new-onset diabetes is a
key strategy for reducing post-transplant cardiovascular
mortality. The individualisation of immunosuppression
guidelines (selection of calcineurin inhibitor and the
steroid dosage) may be an effective measure for control-
ling the incidence of post-transplant diabetes and modi-
fying the cardiovascular risk in this patient group.
Among the limitations of the study, we could point out
that with a view to minimising the selection bias, informa-
tion was collected on all transplants performed during the
study period. There were no significant differences in infor-
mation losses among patients presenting the event of
interest or not. In order to minimise any information
biases, mean values of the baseline measurements closest
in time were calculated. Left ventricular hypertrophy was
diagnosed by ECG. As opposed to previous studies—based
on the retrospective analysis of records, which only
contain information prior to transplantation and from
short-term follow-up—this study provides long-term
information on clinical and analytic parameters and with
regard to the treatment of kidney transplant recipients.
Although the information was gathered from hospital
medical records, which could result in an information
bias, the characteristics of these patients mean that they
are subject to much more exhaustive follow-up than is ha-
bitual, not only during the period immediately after trans-
plantation, but throughout the entire follow-up period.
Thus, during the first year after kidney transplantation,
patients were seen every 3 months, every 6 months in the
10 years following a transplant, and once a year after the
first 10 years of follow-up. The study included a large co-
hort of patients with a long period of post-transplantation
follow-up, which has enabled us to obtain valid results on
the long-term results of kidney transplantation. Among
the confounding biases, it should be noted that there are
risks factors which were not included, information in
relation with the heart failure according to the functional
state was not available and also the level of HbA1c
expressing glicemic control in diabetics was not included.
Treatments, which modify the variables studied, were not
included. In order to control the confusion, we have
employed multivariate regression techniques. The popula-
tion at risk changes over time in a population of survivors
due to the occurrence of competing events. It is possible
that the presence of competing events has an impact on
the effect estimates over time.
Seoane-Pillado et al. BMC Cardiovascular Disorders  (2017) 17:72 Page 6 of 7The majority of the studies published in the literature
employ the habitual survival analysis techniques, assum-
ing that there is only one event of interest, and that
censoring is not informative; i.e., that if we monitored
censored patients, they would have the same rate for the
event as non-censored patients [22]. In practice these
assumptions are not always correct; generally speaking,
an individual may experience more than one type of
event, or experience a type of event which hinders or
modifies the probability of observing the event of interest.
Competing risk survival analysis enables us to determine
the factors associated with the incidence of a specific
event. Fine & Gray [12] modified Cox’s proportional risk
model to take into account competing risks.
It is becoming progressively easier to secure compre-
hensive data sets with full follow-up; consequently, the
need to apply mathematical methodologies focused on
the precise type of analysis is also increasing. Owing to
the foregoing, our principal aim must be to apply
specific techniques, such as competing risks, from the
design phase of the study up to the interpretation of the
results obtained.
Conclusions
This study has made it possible to determine, in a cohort
of kidney transplant recipients, and taking into account
competing events, the post-transplant incidence of said
events and the risk factors associated with the same.
Modifiable risk factors have been identified, owing to
which, said factors would have a bearing of the incidence
of cardiovascular events in this patient group.
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